Alopecia Treatment Market 2021 | Industry Trends, Growth, Size, Demand and Forecast by 2026

According to the latest report by IMARC Group, titled, “Alopecia Treatment Market Share: Global Industry Trends, Size, Growth, Opportunity and Forecast 2021-2026“, the global Alopecia Treatment Market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026.

Alopecia is an autoimmune disorder affecting the hair follicles that prevents the growth of hair on the scalp, face and body. Often resulting in hair loss and even baldness, it is commonly caused as a result of unhealthy diets, age, lifestyle changes, hormonal imbalance and hypertension. Its treatment aims to stimulate hair growth by suppressing the immune system. Some of the widely used drugs for treating alopecia include corticosteroids, minoxidil and anthralin.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/alopecia-treatment-market/requestsample

Market Trends

The global market is primarily driven by significant growth in the healthcare industry. Along with this, continual technological advancements across the sector are contributing to the market growth. For instance, the increasing deployment of advanced technologies, such as low light laser therapy (LLLT) that is safer and less invasive, is creating a positive outlook for the market. Moreover, the rising preference for maintaining an aesthetic appearance among the masses due to the growing popularity of social media is acting as a major growth-inducing factor. Other factors, including the increasing healthcare expenditure and extensive research and development (R&D) activities, are also providing an impetus to the market growth.

NoteWe are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

  • Aclaris Therapeutics Inc.
  • Cellmid Limited
  • Cipla Limited
  • Reddy’s Laboratories Ltd.
  • GlaxoSmithKline plc
  • HCell Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Taisho Pharmaceutical Holdings Co Ltd
  • Teva Pharmaceutical Industries Ltd.

The report has segmented the market based on Component, Deployment Mode, Organization Size, Business Function, Industry Vertical and Region.

Breakup by Drug Type:

  • Minoxidil
  • Finasteride
  • Others

Breakup by Indication:

  • Androgenic Alopecia
  • Alopecia Areata
  • Alopecia Totalis
  • Others

Breakup by Gender:

  • Male
  • Female

Breakup by Route of Administration:

  • Oral
  • Topical
  • Injectable

Breakup by Distribution Channel:

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

Breakup by Region:

  • North America
  • Asia-Pacific
  • Europe
  • Latin America
  • Middle East and Africa

Table of Content:

1    Preface
2    Scope and Methodology

2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

4.1    Overview
4.2    Key Industry Trends
5    Global Alopecia Treatment Market
5.1    Market Overview
5.2    Market Performance
5.3    Impact of COVID-19
5.4    Market Forecast
6    Market Breakup by Drug Type
6.1    Minoxidil
6.1.1 Market Trends
6.1.2 Market Forecast
6.2    Finasteride
6.2.1 Market Trends
6.2.2 Market Forecast
6.3    Others
6.3.1 Market Trends
6.3.2 Market Forecast
7    Market Breakup by Indication
7.1    Androgenic Alopecia
7.1.1 Market Trends
7.1.2 Market Forecast
7.2    Alopecia Areata
7.2.1 Market Trends
7.2.2 Market Forecast
7.3    Alopecia Totalis
7.3.1 Market Trends
7.3.2 Market Forecast
7.4    Others
7.4.1 Market Trends
7.4.2 Market Forecast
8    Market Breakup by Gender
8.1    Male
8.1.1 Market Trends
8.1.2 Market Forecast
8.2    Female
8.2.1 Market Trends
8.2.2 Market Forecast
9    Market Breakup by Route of Administration
9.1    Oral
9.1.1 Market Trends
9.1.2 Market Forecast
9.2    Topical
9.2.1 Market Trends
9.2.2 Market Forecast
9.3    Injectable
9.3.1 Market Trends
9.3.2 Market Forecast
10    Market Breakup by Distribution Channel
10.1    Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2    Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3    Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11    Market Breakup by Region
11.1    North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2    Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3    Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4    Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5    Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12    SWOT Analysis
12.1    Overview
12.2    Strengths
12.3    Weaknesses
12.4    Opportunities
12.5    Threats
13    Value Chain Analysis
14    Porters Five Forces Analysis

14.1    Overview
14.2    Bargaining Power of Buyers
14.3    Bargaining Power of Suppliers
14.4    Degree of Competition
14.5    Threat of New Entrants
14.6    Threat of Substitutes
15    Price Analysis
16    Competitive Landscape

16.1    Market Structure
16.2    Key Players
16.3    Profiles of Key Players
16.3.1    Aclaris Therapeutics Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.2    Cellmid Limited
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.3    Cipla Limited
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4    Dr. Reddy’s Laboratories Ltd.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5    GlaxoSmithKline plc
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6    HCell Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7    Johnson & Johnson
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8    Merck & Co. Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9    Pfizer Inc.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10    Taisho Pharmaceutical Holdings Co. Ltd
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.11    Teva Pharmaceutical Industries Ltd.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Website: https://www.imarcgroup.com
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800

About MarcelMikaelson

Check Also

7 Top-Notch EMF Products for a Safer Environment

Highlights Understand EMF Radiation’s two types – extremely low frequency (ELF) and radio frequency (RF). …

Leave a Reply

Your email address will not be published. Required fields are marked *